A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
收藏DataCite Commons2025-11-11 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00011942/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The reason for this study is to see if the study drug mirikizumab is safe and effective in participants with moderately to severely active Crohn's disease.
提供机构：
Vivli
创建时间：
2025-11-11
